Terra Innovatum Global N.V.

Pre-revenue micro-modular nuclear developer with a ~$607M accumulated deficit and binary commercialization risk; deployment not targeted until 2028.

Strengths

• ~$103M cash post-SPAC provides near-term runway
• Differentiated LEU-based SOLO design with NRC engagement underway

Risks

• No revenue since inception, persistent operating losses and negative operating cash flow; solvency depends on further capital raises
• Binary, multi-year regulatory/commercialization risk with only non-binding customer MOUs

Notable findings

• Exec changeRecent 8-K item 5.02 8-K ↗
• Auditor changeRecent 8-K item 4.01 8-K ↗
• Strong balance sheetStrong balance sheet — $103M cash & investments